Mr. Mike Withrow reports

AREV BRANDS INTERNATIONAL LTD. ANNOUNCES REACHING A MAJOR MILESTONE

AREV Brands International Ltd. has reached a major milestone in its joint development project with Alternative Extracts Inc. The research work conducted was with oil-based extracts from non-regulated sources that carry a wide variety of terpenes and related compounds responsible for aroma and flavour. Terpene synthesis is vital for cannabinoid synthesis as it provides the GPP molecule for CBGA synthesis.

The company through its proprietary extraction methods has discovered an efficient way to infuse aqueous solutions with oil-based extracts that include some flavonoids and terpenes. These extracts were infused in non-alcoholic beer, ciders, wine, spritzers, fruit juices and maple water.

The materials used include Hops, Frankincense, Myrrh, Pepper, Lemon Balm, Lavender, Tea Tree oil, Turmeric and oil from hemp seeds. The company has sampled enough material to be confident that it can extract virtually any lipid based terpene and infuse it into an aqueous based product.

These materials contain many valuable terpenes that affect mood and experience when combined with THC. Many of these terpenes are destroyed in the decarboxylation process that is performed to activate THC.

AREV can now preserve the valuable terpenes found in medicinal plants while also having the potential to serve as a natural preservative. This is key in non alcoholic beers, which have a short shelf life, and will be of use in other AREV products. We can also create flavour profiles with the flavonoid and terpene extracts and in some cases amplify the entourage effect.

AREV invites any Health Canada Licensed Producer or beverage manufacturers t o contact the company for further discussions on this breakthrough that will dramatically reduce their product development cycle.

Mike Withrow commented "We are ecstatic about this discovery and how the purity and quality of the extracts from the extraction system are performing. It is potentially a game changer for those incumbents in the cannabis and beverage space."

Dr. Adrian Wade, Chief Science Officer, of Alternative Extracts Inc. commented "AREV's extractors produce the highest quality products, including terpenes. Terpenes provide distinctive aromas in plants and play an important role in an increasing number of health food products. The ability to readily infuse pure, naturally sourced terpenes into beverages provides the consumer with aromas that are closest to nature."

The Company announces it has settled $150,000 in debt with Alternative Extracts Inc. by the issuance of 500,000 Shares at $0.30. Alternative Extracts Inc. is a reporting issuer and the majority of the shares of Alternative Extracts are held by Mike Withrow, a director of the Company. The Company has issued 300,000 stock options to Directors and Consultants of the Company at a price of $0.325 for a period of 5 years from the issuance date. These options will vest immediately.

Participation of the insiders of the Company in the shares for debt constitutes a related party transaction as defined under Multilateral Instrument 61-101 (Protection of Minority Security Holders in Special Transactions). Because the Company's shares trade only on the CSE, the issuance of securities is exempt from the formal valuation requirements of Section 5.4 of MI 61-101 pursuant to Subsection 5.5(b) of MI 61-101 and exempt from the minority approval requirements of Section 5.6 of MI 61-101 under 5.7(b).

AREV Nutrition Sciences Inc. ("AREV") produces and delivers functional ingredients from its world-class extraction systems. AREV is revolutionizing the current delivery method of coconut oil, whey protein and nutrients through emulsification. These premium ingredients and products are targeted for the natural health, medical, functional food, nutraceutical, sport nutrition and bioceutical markets. AREV is also working with Pharmacy and Dispensary operators with an innovative emulsified base formula to disperse Cannabis oil extracts from specific selected genetic Cannabis strains that address 5 areas of health including Anxiety, Pain Management, Insomnia, Central Nervous System Disorders & Libido.